Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/18/24 20:48 | 11/18/24 | TNYA | Health | BioPrd | Biological Products, (No Diag | Saito Chihiro | CA | O | SVP,Acco | 2 | S | -12 | 2.52 | 0 | -5 | 63 | D | |||||||||||||||
8/16/24 20:26 | 8/16/23 | TNYA | Health | BioPrd | Biological Products, (No Diag | Tingley Whittemore | CA | O | Chief Me | 3 | S | -81 | 4.14 | 0 | -19 | 107 | D | |||||||||||||||
8/16/24 20:25 | 8/16/23 | TNYA | Health | BioPrd | Biological Products, (No Diag | Ali Faraz | CA | DO | CEO | 3 | S | -87 | 4.00 | 0 | -22 | 188 | D | |||||||||||||||
3/6/24 18:45 | 8/29/23 | TNYA | Health | BioPrd | Biological Products, (No Diag | Hoey Timothy | CA | O | Chief Sc | 5 | S | -132 | 5.10 | 0 | -26 | 255 | D | |||||||||||||||
2/16/24 20:32 | 8/16/23 | TNYA | Health | BioPrd | Biological Products, (No Diag | Patterson Leone D | CA | O | Chief Fi | 2 | S | -47 | 4.91 | 0 | -10 | 65 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |